Drugs / VBP-245
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03077750 | Feb 2017 → Mar 2018 | molluscum contagiosum | Veloce BioPharma LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VBP-245 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03077750 ↗ |
| Route | Topical | “Topical application BID” NCT03077750 ↗ |